SAR288 has emerged as a promising therapeutic target for COVID-19. This drug compound exhibits remarkable antiviral properties against SARS-CoV-2, the virus responsible for COVID-19. Preclinical studies have https://keithwyky552936.blogdigy.com/a-novel-therapeutic-target-for-covid-19-59773683